825 INDUSTRIAL ROAD, SAN CARLOS, CA
Director Retirement - Wendy Yarno Not Standing for Re-Election
Highlights Strong Fourth Quarter and Full Year 2025 Results, Business Achievements and Corporate Updates
Corporate Overview January 2026
Highlights Business Achievements, Pipeline Milestones, and Third Quarter 2025 Results
Investor Presentation
News, Underwriting Agreement, Legal Opinion
Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced Melanoma
Reports Financial Results and Corporate Updates for Second Quarter and First Half 2025
FY 2024
Q3
Q2
Q1
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
Additional Proxy Materials
PRER14A
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Submission Upload
Correspondence